GoodRx Holdings, Inc. Class A (GDRX)

GoodRx Holdings, Inc. stock has experienced significant volatility and a notable decline over the past six months. Key events impacting the stock include a Q4 CY2025 earnings report with cautious 2026 revenue guidance, leadership changes, analyst downgrades and price target cuts, and a partnership with Viatris.

While specific detailed seasonal patterns for GoodRx's products and services are not extensively detailed in public reports, the company has acknowledged increased utilization from seasonal factors. However, its prescription transactions revenue has been in decline since the COVID era, and monthly active consumers have been decreasing. Telehealth demand has long-term potential as a hybrid model of care.

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform providing information and tools for consumers to compare prices and save on prescription drugs in the United States. Its services include prescription drug price comparison, a telemedicine platform (GoodRx Care), pharma manufacturer solutions (Pharma Direct), subscription programs like GoodRx Gold, and healthcare products for pets.

GoodRx Holdings, Inc. is headquartered in Santa Monica, California, and primarily focuses on the U.S. market, with its prescription price comparison services available at over 75,000 pharmacies nationwide.

GoodRx's brand reputation has faced challenges, with reports indicating a decline in its visibility and appeal among consumers. This is partly attributed to customer attrition and increased competition. A significant historical event impacting GoodRx's reputation was the Federal Trade Commission (FTC) enforcement action in February 2023.

GoodRx Holdings, Inc. has a diversified ownership structure, including institutional investors, its founders, and the public. Institutional ownership accounts for approximately 35.80% of outstanding stock, insiders hold about 15.98%, and retail investors own roughly 48.22%. Major institutional owners include Francisco Partners Management, LP, The Vanguard Group, Inc., and Silver Lake Group, L.L.C. Key individual owners and insiders include Abdiel Capital Management, Llc, Trevor Bezdek, Douglas Joseph Hirsch, and Andrew Slutsky.